NeuroSigma partners with South Korea’s KT to develop electronic therapies
The partnership is also expected to see an investment by KT in NeuroSigma
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 Jun 21
The partnership is also expected to see an investment by KT in NeuroSigma
14 Jun 21
The new technology-as-a-service (TaaS) bundle combines the ActivSight delivery system with the ActivInsights software suite
14 Jun 21
The Operations Dashboard is the newest PartsSource Pro expansion designed to improve the reliability and resiliency of clients’…
14 Jun 21
Lateral flow antigen tests are intended to provide a cost effective and rapid means of identifying individuals with…
14 Jun 21
British Columbia joins Yukon, Quebec and Saskatchewan to offer public coverage of CGM systems under provincial health plans
11 Jun 21
New findings around the AI prediction of genetic subtypes in pancreatic cancer tumours could be useful in cancer…
The company is planning to commercially introduce the Flexcera resin in Europe in late summer
11 Jun 21
Enters into exclusive distribution agreement with Patia Europe SL, developer of DIABETESpredict
11 Jun 21
Dose TR contains a novel formulation of travoprost, a prostaglandin analog used to reduce IOP
10 Jun 21
The qualitative in vitro diagnostic test will help identify antibodies to SARS-CoV-2 in serum